Merck targets commercialization of next-gen chip technology amid AI boom
전체 맥락을 이해하기 위해서는 본문 보기를 권장합니다.
Merck, a German chemical and technology giant, plans to commercialize next-generation chip manufacturing technology dubbed "Directed Self-Assembly" in the "next couple of years."
"You've heard about how expensive the EUV process is and how expensive the equipment is," said Merck's Chief Commercial Officer and Executive Vice President Anand Nambiar at a press event in southern Seoul. "We believe that DSA brings down the cost of ownership in EUV equipment. We also believe that the EUV technology also has limitations and DSA will be a needed, complementary technology to shrink patterns even further from where we are today."
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
Merck, a German chemical and technology giant, plans to commercialize next-generation chip manufacturing technology dubbed “Directed Self-Assembly” in the "next couple of years."
Directed Self-Assembly (DSA) is a technology that uses chemical processes to create precise chip patterns at smaller scales. The technology could simplify the production process to pattern silicon wafers used in chips, said Merck.
Merck believes that the AI boom has further triggered acceleration into the semiconductor market as high-performance chips are crucial in creating more advanced generative AIs. The global AI chip market is expected to grow to $400 billion business by 2027 from the current $50 billion — and possibly grow to the scale of $1 trillion in the next seven to 10 years, according to Merck data.
Merck’s involvement in the electronics sector revolves around supplying materials in semiconductor manufacturing. Merck’s current key focus is integrating DSA technology with extreme ultraviolet (EUV) lithography.
When the technology is applied to EUV lithography, an advanced chip manufacturing technique used to create intricate patterns on a silicon wafer, the production process could be simplified and importantly, bring down costs, according to Merck.
“You’ve heard about how expensive the EUV process is and how expensive the equipment is,” said Merck’s Chief Commercial Officer and Executive Vice President Anand Nambiar at a press event in southern Seoul. “We believe that DSA brings down the cost of ownership in EUV equipment. We also believe that the EUV technology also has limitations and DSA will be a needed, complementary technology to shrink patterns even further from where we are today.”
Nambiar said that utilizing DSA technology could “remove two EUV steps — which is significant” and aims to have the technology commercialized over the next couple of years.
Nambiar said that the company is engaged in collaborative research and development on this new technology with global chip leaders, including those from Korea, although he did not specify the names of the companies involved.
BY LEE JAE-LIM [lee.jaelim@joongang.co.kr]
Copyright © 코리아중앙데일리. 무단전재 및 재배포 금지.
- Rapper Jessi ends contract with agency More Vision
- President Yoon likely to address nation in pre-taped interview amidst first lady controversy
- 15-year-old who attacked lawmaker with a rock also ‘threw coffee at actor Yoo Ah-in’
- (G)I-DLE drops '2' for every 'Super Lady' as group powers through health, lyric fights
- 'A delicious bibimbap-like drama': Choi Woo-shik says 'A Killer Paradox' has it all
- Gov't to raise med school enrollment amid doctor shortage
- Nude model Ha Young-eun bares all with her first book
- Who should qualify as a 'senior citizen?'
- 'Leading-edge players' may have head start on Chips Act subsidies: U.S. official
- Hong Eun-chae of Le Sserafim to take temporary health break